Contributors

About the Authors

  • The Authors of "Patent Docs" are patent attorneys who hold doctorates in a diverse array of biotech and chemical disciplines.

Contact the Docs

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter. When a new article is posted during the day, you will receive it by e-mail the next morning.

Enter your email address:

Delivered by FeedBurner

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.

« More on House Subcommittee USPTO Oversight Hearing | Main | 23rd Annual ABA Intellectual Property Law Conference »

February 29, 2008

PharmaBiotech IP Summit

    By Jason Derry --

Pharmabiotech08_2 The 2008 PharmaBiotech IP Summit, organized by Worldwide Business Research, will occur in Philadelphia at the Ritz-Carlton, May 28-30.  The conference, "Protect Critical Patents and Drive Sustainable Growth Through IP-Driven Business Strategies," consists of two main conference days and a master class.  The Patent Protection and Enforcement Masterclass occurs on May 28, and covers topics such as the upcoming regulations, lifecycle extension relative to assessing best time to file applications, the new IDS rules, changes to Markush practice, avoiding inequitable conduct in prosecution, and the Examiners' guidelines on obviousness.

According to the conference website, the Summit will enable its attendees to:

• Effectively navigate recent and potential regulatory changes to ensure long term protection and enforcement of your patents.
• Enhance strategic management of your portfolio to get the best out of it.
• Implement innovative ways to extend the useful life cycle of your most commercially valuable assets.
• Meld IP and business strategies to become a true partner of the business and drive future growth.

CLE credit is available.  For more information, including the agenda and registration information, visit the PharmaBiotech Summit IP website.

Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/t/trackback/1117334/26665262

Listed below are links to weblogs that reference PharmaBiotech IP Summit:

Comments

Post a comment

May 2008

Sun Mon Tue Wed Thu Fri Sat
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Google Search